Compare Enveric Biosciences Inc (ENVB) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.69M), while Direxion Daily TSLA Bull 2X Shares trades at $10.23 (market cap $4.08B). The key difference: Direxion Daily TSLA Bull 2X Shares is far larger — about 609.9× Enveric Biosciences Inc's market cap, and Direxion Daily TSLA Bull 2X Shares is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Direxion Daily TSLA Bull 2X Shares for 15 Days on average.
| ENVB | TSLL | |
|---|---|---|
Market Cap | $6.69M | $4.08B |
Volume | 41,141 | 46,206,477 |
Sector | Health | Leveraged / Inverse |
52-Week High | $10.80 | $23.03 |
52-Week Low | $1.27 | $6.74 |
Typical Hold Time | 14 Days | 15 Days |
Enterprise Value | -$1.60M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495, up 1.7% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten EPS expectations. Recent news includes a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in an investment conference.
The outlook remains speculative given the lack of revenue and negative profitability, but analyst consensus is bullish with 75% buy ratings. Key risks include the pre-revenue biotech model and dependence on successful drug development. Upside potential hinges on clinical progress and regulatory milestones for its psychiatric therapeutics pipeline.
TSLL, the Direxion Daily TSLA Bull 2X Shares ETF, trades at $10.15, down 1.55% on the day. The overall technical signal is bullish, supported by moving averages, while oscillators are neutral. Recent news highlights its sensitivity to Tesla's stock movements, with a notable rally tied to Cybercab hype. As a leveraged ETF, it aims to deliver twice Tesla's daily returns, amplifying both gains and losses.
The outlook for TSLL is directly tied to Tesla's performance, offering high-risk, high-reward exposure. Key risks include volatility decay from daily rebalancing and dependence on Tesla-specific events. Investors seeking amplified Tesla returns may find opportunity, but must be wary of the inherent leverage risks in a volatile stock.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
